The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Open accessAbstract
The electronic properties and relatively small size of fluorine endow it with considerable versatility as a bioisostere and it has found application as a substitute for lone pairs of electrons, the hydrogen atom, and the methyl group while also acting as a functional mimetic of the carbonyl, carbinol, and nitrile moieties. In this context, fluorine substitution can influence the potency, conformation, metabolism, membrane permeability, and P-gp recognition of a molecule and temper inhibition of the hERG channel by basic amines. However, as a consequence of the unique properties of fluorine, it features prominently in the design of higher order structural metaphors that are more esoteric in their conception and which reflect a more sophisticated molecular construction that broadens biological mimesis. In this Perspective, applications of fluorine in the construction of bioisosteric elements designed to enhance the in vitro and in vivo properties of a molecule are summarized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–253 of 253
Bahta, M., Lountos, G. T., Dyas, B. K., Kim, S., Ulrich, R. G., Waugh, D. S., & Burke, T. R. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200022g · Cited by 42
Ontoria, J. M., Marco, S. D., Conte, I., Francesco, M. E. D., Gardelli, C., Koch, U., Matassa, V. G., Poma, M., Steinkühler, C., Volpari, C., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049435d · Cited by 42
Chern, J., Leu, Y.-L., Wang, S., Jou, R., Lee, C.-F., Tsou, P.-C., Hsu, S., Liaw, Y., & Lin, H.-M. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9607818 · Cited by 42
Huang, H., Hutta, D. A., Rinker, J. M., Hu, H., Parsons, W. H., Schubert, C., DesJarlais, R. L., Crysler, C. S., Chaikin, M. A., Donatelli, R. R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801406h · Cited by 42
Karad, S. N., Pal, M., Crowley, R. S., Prisinzano, T. E., & Altman, R. A. (2017) · ChemMedChem · doi:10.1002/cmdc.201700103 · Cited by 40
Huang, X., Cheng, C. C., Fischmann, T. O., Duca, J. S., Richards, M. P., Tadikonda, P. K., Reddy, P. A., Zhao, L., Siddiqui, M. A., Parry, D., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.02.108 · Cited by 38
Ettaoussi, M., Sabaouni, A., Rami, M., Boutin, J. A., Delagrange, P., Renard, P., Spedding, M., Caignard, D., Berthelot, P., & Yous, S. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.01.027 · Cited by 38
Lapierre, J., Ahmed, V. F., Chen, M.-J., Ispahany, M., Guillemette, J. G., & Taylor, S. D. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.089 · Cited by 38
Koller, A. N., Božilović, J., Engels, J. W., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1237 · Cited by 37
Mantlo, N. B., & Escribano, A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400574e · Cited by 37
METABOLIC ACTIVATION OF FLUOROPYRROLIDINE DIPEPTIDYL PEPTIDASE-IV INHIBITORS BY RAT LIVER MICROSOMES
Xu, S. S., Zhu, B., Teffera, Y., Pan, D., Caldwell, C. G., Doss, G. A., Stearns, R. A., Evans, D. C., & Beconi, M. G. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001842 · Cited by 37
Pettersson, M., Johnson, D. S., Humphrey, J. M., Butler, T. W., Ende, C. W. A., Fish, B. A., Green, M., Kauffman, G. W., Mullins, P. B., O’Donnell, C. J., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00070 · Cited by 36
Novel Steroidal Vinyl Fluorides as Inhibitors of Steroid C17(20) Lyase
Burkhart, J. P., Weintraub, P. M., Gates, C. A., Resvick, R. J., Vaz, R. J., Friedrich, D., Angelastro, M. R., Bey, P., & Peet, N. P. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00354-6 · Cited by 33
Fluorinated Olefinic Peptide Nucleic Acid: Synthesis and Pairing Properties with Complementary DNA
Hollenstein, M., & Leumann, C. J. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo047753e · Cited by 32
Luzina, E. L., & Popov, A. V. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.03.026 · Cited by 32
Fluorine multipolar interaction: Toward elucidating its energetics in binding recognition
Li, X., Keefer, C. E., & Brown, M. F. (2016) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2016.12.013 · Cited by 32
Anticonvulsant and antiepileptogenic effects of fluorofelbamate in experimental status epilepticus
Mazarati, A. M., Sofia, R. D., & Wasterlain, C. G. (2002) · Seizure · doi:10.1053/seiz.2002.0677 · Cited by 31
Sharma, R., Sun, H., Piotrowski, D. W., Ryder, T. F., Doran, S. D., Dai, H. I., & Prakash, C. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.047316 · Cited by 31
Steroid derivatives as inhibitors of steroid sulfatase
Mostafa, Y. A., & Taylor, S. D. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.01.013 · Cited by 30
A Pyridazine Series of α2/α3 Subtype Selective GABAA Agonists for the Treatment of Anxiety
Lewis, R. T., Blackaby, W., Blackburn, T. J., Jennings, A. S. R., Pike, A. J., Wilson, R. A., Hallett, D. J., Cook, S. M., Ferris, P., Marshall, G. R., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051144x · Cited by 30
Chen, Z., Wang, R., & Qing, F. (2012) · Tetrahedron Letters · doi:10.1016/j.tetlet.2012.02.062 · Cited by 29
Corina, D. L., Miller, S. L., Wright, J. N., & Akhtar, M. (1991) · Journal of the Chemical Society Chemical Communications · doi:10.1039/c39910000782 · Cited by 28
Liu, Y., Ahmed, V. F., Hill, B., & Taylor, S. D. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b508852f · Cited by 28
Nuzzi, A., Fiasella, A., Ortega, J. A., Pagliuca, C., Ponzano, S., Pizzirani, D., Bertozzi, S. M., Ottonello, G., Tarozzo, G., Reggiani, A. M., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.046 · Cited by 28
Nakajima, Y., Inoue, T., Nakai, K., Mukoyoshi, K., Hamaguchi, H., Hatanaka, K., Sasaki, H., Tanaka, A., Takahashi, F., Kunikawa, S., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.05.034 · Cited by 27
Irregularities in enzyme assays: The case of macrophage migration inhibitory factor
Cisneros, J. A., Robertson, M. J., Valhondo, M., & Jorgensen, W. L. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.04.074 · Cited by 27
Hemeryck, A., Vriendt, C. D., & Belpaire, F. M. (2001) · PubMed · Cited by 26
Discovery of a novel series of quinolone α7 nicotinic acetylcholine receptor agonists
McDonald, I. M., Mate, R. A., Zusi, F. C., Huang, H. B., Post-Munson, D. J., Ferrante, M. A., Gallagher, L., Bertekap, R. L., Knox, R. J., Robertson, B., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.01.070 · Cited by 25
Mechanism and stereochemistry of .alpha.,.beta.-dihydroxyacid dehydratase
Pirrung, M. C., Holmes, C. P., Horowitz, D. M., & Nunn, D. S. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00003a042 · Cited by 24
Targeted Fluorination of a Nonsteroidal Anti‐inflammatory Drug to Prolong Metabolic Half‐Life
Shaughnessy, M. J., Harsányi, A., Li, J., Bright, T. V., Murphy, C. D., & Sandford, G. (2014) · ChemMedChem · doi:10.1002/cmdc.201300490 · Cited by 24
Crawford, J. J., Kenny, P. W., Bowyer, J., Cook, C., Finlayson, J., Heyes, C., Highton, A. J., Hudson, J. A., Jestel, A., Krapp, S., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301119s · Cited by 24
Koeller, S., Thomas, C., Peruch, F., Deffieux, A., Massip, S., Léger, J., Desvergne, J., Milet, A., & Bibal, B. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201303662 · Cited by 23
Kobayakawa, T., Matsuzaki, Y., Hozumi, K., Nomura, W., Nomizu, M., & Tamamura, H. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00234 · Cited by 23
Purification and inhibition of spinach .alpha.,.beta.-dihydroxyacid dehydratase
Pirrung, M. C., Ha, H. J., & Holmes, C. P. (1989) · The Journal of Organic Chemistry · doi:10.1021/jo00268a014 · Cited by 22
Berry, C. B., Bubser, M., Jones, C. K., Hayes, J. P., Wepy, J. A., Locuson, C. W., Daniels, J. S., Lindsley, C. W., & Hopkins, C. R. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500267c · Cited by 22
Preparation and Evaluation of Potent Pentafluorosulfanyl‐Substituted Anti‐Tuberculosis Compounds
Moraski, G. C., Bristol, R., Seeger, N., Boshoff, H. I., Tsang, P. S., & Miller, M. J. (2017) · ChemMedChem · doi:10.1002/cmdc.201700170 · Cited by 22
The Role of Fluorine in the Discovery and Optimization of CNS Agents
Hodgetts, K. J., Combs, K. J., Elder, A. M., & Harriman, G. C. B. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45026-5 · Cited by 21
Blackburn, G. M., & Türkmen, H. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b417327a · Cited by 20
Ye, X. M., Konradi, A. W., Smith, J. L., Aubele, D. L., Garofalo, A. W., Marugg, J. L., Neitzel, M. L., Semko, C. M., Sham, H. L., Sun, M., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.148 · Cited by 20
Design and synthesis of orally available MEK inhibitors with potent in vivo antitumor efficacy
Adams, M. E., Wallace, M. B., Kanouni, T., Scorah, N., O’Connell, S. M., Miyake, H., Shi, L., Halkowycz, P., Zhang, L., & Dong, Q. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.02.026 · Cited by 19
FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
Giudici, D., Briatico, G., Cominato, C., Zaccheo, T., Iehlé, C., Nesi, M., Panzeri, A., & di Salle, E. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(96)00040-4 · Cited by 19
Metabolism study and biological evaluation of bosentan derivatives
Lepri, S., Goracci, L., Valeri, A., & Cruciani, G. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.06.006 · Cited by 18
Ahmad, S., Washburn, W. N., Hernández, A. S., Bisaha, S. N., Ngu, K., Wang, W., Pelleymounter, M. A., Longhi, D., Flynn, N., Azzara, A. V., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00676 · Cited by 18
Li, X., Singh, S. M., Luu-The, V., Côté, J., Laplante, S., & Labrie, F. (1996) · Bioorganic & Medicinal Chemistry · doi:10.1016/0968-0896(95)00160-3 · Cited by 17
Xiamuxi, H., Wang, Z., Li, J., Wang, Y., Wu, C., Yang, F., Jiang, X., Liu, Y., Zhao, Q., Chen, W., et al. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.07.040 · Cited by 17
4‐Aryl‐Substituted 2,5‐Dimethoxyphenethylamines: Synthesis and Serotonin 5‐HT2AReceptor Affinities
Trachsel, D., Nichols, D. E., Kidd, S., Hadorn, M., & Baumberger, F. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200800235 · Cited by 16
Pallan, P. S., Prakash, T. P., de Leon, A. R., & Egli, M. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00849 · Cited by 16
Optimization of a novel series of potent and orally bioavailable GPR119 agonists
Koshizawa, T., Morimoto, T., Watanabe, G., Watanabe, T., Yamasaki, N., Sawada, Y., Fukuda, T., Okuda, A., Shibuya, K., & Ohgiya, T. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.06.034 · Cited by 15
Zlotos, D. P., Riad, N. M., Osman, M. B., et al. (2015) · MedChemComm · doi:10.1039/c5md00190k · Cited by 11
Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors
Garton, N. S., Barker, M. D., Davis, R. P., Douault, C., Hooper‐Greenhill, E., Jones, E. J., Lewis, H. D., Liddle, J., Lugo, D., McCleary, S., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.08.070 · Cited by 11
Du, J., Hua, G., Beier, P., Slawin, A. M. Z., & Woollins, J. D. (2016) · Structural Chemistry · doi:10.1007/s11224-016-0854-2 · Cited by 11
In silico structural prediction of human steroid 5α-reductase type II
Karnsomwan, W., Rungrotmongkol, T., De‐Eknamkul, W., & Chamni, S. (2016) · Medicinal Chemistry Research · doi:10.1007/s00044-016-1541-y · Cited by 6
Cited by
Direct Photocatalyzed Hydrogen Atom Transfer (HAT) for Aliphatic C–H Bonds Elaboration
Capaldo, L., Ravelli, D., & Fagnoni, M. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00263 · Cited by 1,342
Marshall, C. M., Federice, J. G., Bell, C. N., Cox, P. B., & Njardarson, J. T. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01122 · Cited by 1,064
U.S. FDA Approved Drugs from 2015–June 2020: A Perspective
Bhutani, P., Joshi, G., Raja, N., Bachhav, N., Rajanna, P. K., Bhutani, H., Paul, A. T., & Kumar, R. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01786 · Cited by 815
Speckmeier, E., Fischer, T. G., & Zeitler, K. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b08933 · Cited by 771
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds
Johnson, B. M., Shu, Y.-Z., Zhuo, X., & Meanwell, N. A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01877 · Cited by 719
Self-citation
Metadata
- Authors
- Meanwell, N. A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-02-05
- Volume
- 61
- Issue
- 14
- Pages
- 5822-5880
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2785609333
- Cited by
- 2,655
- References
- 253
- FWCI
- 79.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.